MeiraGTx Holdings (MGTX) Liabilities and Shareholders Equity (2017 - 2025)

MeiraGTx Holdings (MGTX) reported Liabilities and Shareholders Equity of $244.4 million for Q4 2025, down 9.39% on a YoY basis from $269.8 million in Q4 2024, and up 29.01% quarter-over-quarter from $189.5 million in Q3 2025.

MeiraGTx Holdings (MGTX) Liabilities and Shareholders Equity (2017 - 2025) Analysis & Trends

MeiraGTx Holdings has reported Liabilities and Shareholders Equity for 9 years, with the latest figure at $244.4 million in Q4 2025.

  • For the quarter ending Q4 2025, Liabilities and Shareholders Equity fell 9.39% year-over-year to $244.4 million; the trailing twelve-month figure through Dec 2025 stood at $856.6 million (down 25.19% YoY), and the FY2025 full-year result was $244.4 million, down 9.39% from the prior year.
  • Liabilities and Shareholders Equity for Q4 2025 stood at $244.4 million, up from $189.5 million in the prior quarter.
  • The five-year high for Liabilities and Shareholders Equity was $339.7 million in Q1 2021, with the low at $189.5 million in Q3 2025.
  • Historically, Liabilities and Shareholders Equity has averaged $282.2 million across 5 years, with a median of $293.8 million in 2023.
  • Annual changes were most pronounced in 2023 — Liabilities and Shareholders Equity advanced 22.9% — and 2025, when it sank 36.74%.
  • MeiraGTx Holdings' Liabilities and Shareholders Equity stood at $320.2 million in 2021, then retreated by 0.6% to $318.2 million in 2022, then advanced by 2.67% to $326.7 million in 2023, then slipped by 17.44% to $269.8 million in 2024, then decreased by 9.39% to $244.4 million in 2025.
  • The last three Liabilities and Shareholders Equity figures came in at $244.4 million (Q4 2025), $189.5 million (Q3 2025), and $198.7 million (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 37.37 Mn
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - 811.27 Mn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 14.93 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 1.73 Bn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - 23.64 Mn
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 33.89 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 12.81 Mn
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 26.48 Bn
9 Abivax 91.96 Bn 91.96 Bn - 640.56 Mn
10 MeiraGTx Holdings 910.47 Mn 844.54 Mn 74.89 Mn 244.43 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 244.43 Mn
Sep 30, 2025 189.47 Mn
Jun 30, 2025 198.72 Mn
Mar 31, 2025 224.01 Mn
Dec 31, 2024 269.75 Mn
Sep 30, 2024 299.49 Mn
Jun 30, 2024 266.65 Mn
Mar 31, 2024 309.24 Mn
Dec 31, 2023 326.74 Mn
Sep 30, 2023 267.19 Mn
Jun 30, 2023 310.26 Mn
Mar 31, 2023 288.14 Mn
Dec 31, 2022 318.24 Mn
Sep 30, 2022 301.41 Mn
Jun 30, 2022 252.46 Mn
Mar 31, 2022 287.69 Mn
Dec 31, 2021 320.16 Mn
Sep 30, 2021 303.34 Mn
Jun 30, 2021 326.77 Mn
Mar 31, 2021 339.68 Mn